This page provides UC Berkeley and agency guidance for UC Berkeley investigators related to Coronavirus Disease 2019 (COVID-19) and human subjects research. The page will be updated as new information is available.

The Office for Protection of Human Subjects continues to operate during normal business hours with staff working remotely. If you have any questions, please don't hesitate to email the OPHS staff at but please do not call us.

HIPAA-Compliant Zoom Meetings

Principal investigators: If you are conducting human subjects research that involves the use/transmission and/or collection of Personal Health Information (PHI) that is covered by HIPAA regulations, UC Berkeley does have access to HIPAA-compliant Zoom meetings, which can be associated either with an individual or department (Special Purpose Account) that can be shared amongst team members. Anyone who has the need for a HIPAA-compliant Zoom account, can order one by submitting a service request in the Telecom catalog. For questions about HIPAA-compliant Zoom, they can call 664-9000, options 2,1 or send email to

UC Berkeley

Supplemental Guidelines for Resumption of Human Subjects Research: Supercedes 3/13/2020, 3/20/2020, 6/17/2020, 8/31/2020, 10/1/2020, and 11/5/2020 guidance (4/13/21)

Note: As described in the Supplemental Guidelines for Resumption of Human Subjects Research, linked above, investigators who wish to bring non-affiliated subjects to campus must fill out this tracking sheet each day/week, to list the total number of non-affiliated human subjects scheduled to come to campus over the following days/week. See the Guidelines for additional information.

Previous Guidance

National Institutes of Health

Guidance for NIH-funded Clinical Trials and Human Subjects Studies Affected by COVID-19 (NOT-OD-20-087)

National Science Foundation

NSF Guidance on the Effects of COVID-19 on Human Subjects Research

U.S. Food and Drug Administration

FDA Guidance on Conduct of Clinical Trials of Medical Products during COVID-19 Public Health Emergency